{"PubmedArticle": [{"MedlineCitation": {"OtherID": [], "SpaceFlightMission": [], "KeywordList": [["Endothelial cells", "Matrix metalloproteinase-9", "Nitric oxide", "Nitrite"]], "CitationSubset": ["IM"], "InvestigatorList": [], "OtherAbstract": [], "GeneralNote": [], "PMID": "26614570", "DateCompleted": {"Year": "2016", "Month": "10", "Day": "21"}, "DateRevised": {"Year": "2018", "Month": "12", "Day": "02"}, "Article": {"Language": ["eng"], "ArticleDate": [{"Year": "2015", "Month": "11", "Day": "28"}], "ELocationID": ["10.1007/s00210-015-1192-4"], "Journal": {"ISSN": "1432-1912", "JournalIssue": {"Volume": "389", "Issue": "2", "PubDate": {"Year": "2016", "Month": "Feb"}}, "Title": "Naunyn-Schmiedeberg's archives of pharmacology", "ISOAbbreviation": "Naunyn Schmiedebergs Arch Pharmacol"}, "ArticleTitle": "Sodium nitrite attenuates MMP-9 production by endothelial cells and may explain similar effects of atorvastatin.", "Pagination": {"StartPage": "223", "EndPage": "231", "MedlinePgn": "223-31"}, "Abstract": {"AbstractText": ["Imbalanced matrix metalloproteinase (MMP) activity promotes cardiovascular alterations that are attenuated by statins. These drugs exert pleiotropic effects independent of cholesterol concentrations, including upregulation of nitric oxide (NO) formation and MMP downregulation. However, statins also increase tissue concentrations of nitrites, which activate new signaling pathways independent of NO. We examined whether atorvastatin attenuates MMP-9 production by human umbilical vein endothelial cells (HUVEC) stimulated with phorbol 12-myristate 13-acetate (PMA) by mechanisms possibly involving increased nitrite, and whether this effect results of NO formation. We also examined whether such an effect is improved by sildenafil, an inhibitor of phosphodiesterase-5 which potentiates NO-induced increases in cyclic GMP. MMP activity and nitrite concentrations were measured by gelatin zymography and ozone-based reductive chemiluminescence, respectively, in the conditioned medium of HUVECs incubated for 24 h with these drugs. Phospho-NF\u03baB p65 concentrations were measured in cell lysate to assess NF\u03baB activation. Atorvastatin attenuated PMA-induced MMP-9 gelatinolytic activity by mechanisms not involving NO, although it increased nitrite concentrations, whereas sildenafil had no effects. Combining both drugs showed no improved responses compared to atorvastatin alone. While sodium nitrite attenuated MMP-9 production by HUVECs, adding hemoglobin (NO scavenger) did not affect the responses to nitrite. Neither atorvastatin nor nitrite inhibited PMA-induced increases in phospho-NF\u03baB p65 concentrations. These findings show that sodium nitrite attenuates MMP-9 production by endothelial cells and may explain similar effects exerted by atorvastatin. With both drugs, the inhibitory effects on MMP-9 production are not dependent on NO formation or on inhibition of NF\u03baB activation. Our findings may help to elucidate important new nitrite-mediated mechanisms by which statins affect imbalanced MMP activity in a variety of cardiovascular disease."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology, Ribeir\u00e3o Preto Medical School, University of S\u00e3o Paulo, Av. Bandeirantes, 3900, Ribeir\u00e3o Preto, SP, 14049-900, Brazil."}], "LastName": "Meschiari", "ForeName": "Cesar A", "Initials": "CA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology, Ribeir\u00e3o Preto Medical School, University of S\u00e3o Paulo, Av. Bandeirantes, 3900, Ribeir\u00e3o Preto, SP, 14049-900, Brazil."}], "LastName": "Pinheiro", "ForeName": "Lucas C", "Initials": "LC"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology, Ribeir\u00e3o Preto Medical School, University of S\u00e3o Paulo, Av. Bandeirantes, 3900, Ribeir\u00e3o Preto, SP, 14049-900, Brazil."}], "LastName": "Guimaraes", "ForeName": "Danielle A", "Initials": "DA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Morphology and Physiology, Dental School of Ribeirao Preto, University of Sao Paulo, Ribeirao Preto, SP, Brazil."}], "LastName": "Gerlach", "ForeName": "Raquel F", "Initials": "RF"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology, Ribeir\u00e3o Preto Medical School, University of S\u00e3o Paulo, Av. Bandeirantes, 3900, Ribeir\u00e3o Preto, SP, 14049-900, Brazil. tanus@fmrp.usp.br."}], "LastName": "Tanus-Santos", "ForeName": "Jose E", "Initials": "JE"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "Germany", "MedlineTA": "Naunyn Schmiedebergs Arch Pharmacol", "NlmUniqueID": "0326264", "ISSNLinking": "0028-1298"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Phosphodiesterase 5 Inhibitors"}, {"RegistryNumber": "0", "NameOfSubstance": "RELA protein, human"}, {"RegistryNumber": "0", "NameOfSubstance": "Transcription Factor RelA"}, {"RegistryNumber": "31C4KY9ESH", "NameOfSubstance": "Nitric Oxide"}, {"RegistryNumber": "A0JWA85V8F", "NameOfSubstance": "Atorvastatin"}, {"RegistryNumber": "BW9B0ZE037", "NameOfSubstance": "Sildenafil Citrate"}, {"RegistryNumber": "EC 3.4.24.35", "NameOfSubstance": "MMP9 protein, human"}, {"RegistryNumber": "EC 3.4.24.35", "NameOfSubstance": "Matrix Metalloproteinase 9"}, {"RegistryNumber": "H2D2X058MU", "NameOfSubstance": "Cyclic GMP"}, {"RegistryNumber": "M0KG633D4F", "NameOfSubstance": "Sodium Nitrite"}, {"RegistryNumber": "NI40JAQ945", "NameOfSubstance": "Tetradecanoylphorbol Acetate"}], "MeshHeadingList": [{"QualifierName": ["pharmacology"], "DescriptorName": "Atorvastatin"}, {"QualifierName": [], "DescriptorName": "Cells, Cultured"}, {"QualifierName": ["metabolism"], "DescriptorName": "Cyclic GMP"}, {"QualifierName": [], "DescriptorName": "Dose-Response Relationship, Drug"}, {"QualifierName": [], "DescriptorName": "Down-Regulation"}, {"QualifierName": ["drug effects", "enzymology"], "DescriptorName": "Human Umbilical Vein Endothelial Cells"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["metabolism"], "DescriptorName": "Matrix Metalloproteinase 9"}, {"QualifierName": ["metabolism"], "DescriptorName": "Nitric Oxide"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Phosphodiesterase 5 Inhibitors"}, {"QualifierName": [], "DescriptorName": "Phosphorylation"}, {"QualifierName": ["drug effects"], "DescriptorName": "Signal Transduction"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Sildenafil Citrate"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Sodium Nitrite"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Tetradecanoylphorbol Acetate"}, {"QualifierName": ["metabolism"], "DescriptorName": "Transcription Factor RelA"}]}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Free Radic Biol Med. 2012 Oct 1;53(7):1440-50", "ArticleIdList": ["22892143"]}, {"Citation": "Naunyn Schmiedebergs Arch Pharmacol. 2011 Jun;383(6):547-54", "ArticleIdList": ["21448567"]}, {"Citation": "J Vasc Surg. 2008 Mar;47(3):513-22", "ArticleIdList": ["18295103"]}, {"Citation": "Eur J Pharmacol. 2004 Sep 13;498(1-3):189-94", "ArticleIdList": ["15363994"]}, {"Citation": "Redox Biol. 2013;1(1):40-44", "ArticleIdList": ["23710434"]}, {"Citation": "Pharmacology. 2012;89(1-2):74-82", "ArticleIdList": ["22343316"]}, {"Citation": "J Clin Invest. 2004 Jan;113(1):19-21", "ArticleIdList": ["14702102"]}, {"Citation": "Naunyn Schmiedebergs Arch Pharmacol. 2012 May;385(5):509-17", "ArticleIdList": ["22262021"]}, {"Citation": "Pharmacol Res. 2009 Mar;59(3):167-75", "ArticleIdList": ["19121394"]}, {"Citation": "Basic Clin Pharmacol Toxicol. 2008 Oct;103(4):374-9", "ArticleIdList": ["18834358"]}, {"Citation": "Eur J Nucl Med Mol Imaging. 2012 Mar;39(3):399-407", "ArticleIdList": ["22109668"]}, {"Citation": "Free Radic Biol Med. 2009 May 1;46(9):1298-307", "ArticleIdList": ["19248829"]}, {"Citation": "Free Radic Biol Med. 2007 Sep 15;43(6):987-92", "ArticleIdList": ["17697943"]}, {"Citation": "Crit Care Med. 2007 Jan;35(1):239-45", "ArticleIdList": ["17133179"]}, {"Citation": "Chem Res Toxicol. 2012 May 21;25(5):975-89", "ArticleIdList": ["22449080"]}, {"Citation": "Br J Pharmacol. 2011 Sep;164(2):372-81", "ArticleIdList": ["21434884"]}, {"Citation": "Clin Biochem. 2005 May;38(5):410-4", "ArticleIdList": ["15820769"]}, {"Citation": "Cell Signal. 2005 Mar;17(3):299-310", "ArticleIdList": ["15567061"]}, {"Citation": "Nat Chem Biol. 2005 Nov;1(6):308-14", "ArticleIdList": ["16408064"]}, {"Citation": "Clin Chim Acta. 2008 Aug;394(1-2):72-6", "ArticleIdList": ["18455513"]}, {"Citation": "Mol Cell Biochem. 2013 Jun;378(1-2):127-35", "ArticleIdList": ["23456480"]}, {"Citation": "Redox Biol. 2013 Nov 17;1:578-85", "ArticleIdList": ["24363994"]}, {"Citation": "Cardiovasc Res. 2006 Feb 15;69(3):666-76", "ArticleIdList": ["16426590"]}, {"Citation": "Crit Care Med. 2013 Jul;41(7):e118-24", "ArticleIdList": ["23478656"]}, {"Citation": "Naunyn Schmiedebergs Arch Pharmacol. 2014 Jun;387(6):591-8", "ArticleIdList": ["24658348"]}, {"Citation": "Free Radic Biol Med. 2006 Oct 1;41(7):1044-9", "ArticleIdList": ["16962929"]}, {"Citation": "Mol Cell Biochem. 2012 Jan;360(1-2):393-9", "ArticleIdList": ["21956669"]}, {"Citation": "Physiology (Bethesda). 2013 Nov;28(6):391-403", "ArticleIdList": ["24186934"]}, {"Citation": "Basic Clin Pharmacol Toxicol. 2011 May;108(5):318-25", "ArticleIdList": ["21176109"]}, {"Citation": "Circulation. 2004 Jun 15;109(23 Suppl 1):III39-43", "ArticleIdList": ["15198965"]}, {"Citation": "Atherosclerosis. 2007 Aug;193(2):438-44", "ArticleIdList": ["16938300"]}, {"Citation": "Matrix Biol. 2010 Apr;29(3):194-201", "ArticleIdList": ["19969080"]}, {"Citation": "Free Radic Biol Med. 2012 Aug 15;53(4):701-9", "ArticleIdList": ["22721923"]}, {"Citation": "Nitric Oxide. 2014 Aug 31;40:52-9", "ArticleIdList": ["24878382"]}, {"Citation": "Curr Drug Targets. 2013 Mar;14(3):335-43", "ArticleIdList": ["23316965"]}, {"Citation": "Cancer Lett. 1996 Sep 10;106(2):185-91", "ArticleIdList": ["8844971"]}, {"Citation": "Annu Rev Pharmacol Toxicol. 2005;45:89-118", "ArticleIdList": ["15822172"]}, {"Citation": "Free Radic Biol Med. 2011 Jul 1;51(1):144-52", "ArticleIdList": ["21530643"]}], "ReferenceList": []}], "History": [{"Year": "2015", "Month": "8", "Day": "12"}, {"Year": "2015", "Month": "11", "Day": "11"}, {"Year": "2015", "Month": "11", "Day": "29", "Hour": "6", "Minute": "0"}, {"Year": "2015", "Month": "11", "Day": "29", "Hour": "6", "Minute": "0"}, {"Year": "2016", "Month": "10", "Day": "22", "Hour": "6", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["26614570", "10.1007/s00210-015-1192-4", "10.1007/s00210-015-1192-4"]}}], "PubmedBookArticle": []}